Pyxus Options Hot After Earnings, Korent Update

Pyxus said revenue jumped 10% in the fiscal third quarter

by Karee Venema

Published on Feb 12, 2019 at 2:57 PM

Options volume is running hot on Pyxus International Inc (NYSE:PYX) this afternoon, as the stock heads toward its best day since Oct. 8. At last check, around 18,000 options have been exchanged -- five times the average daily volume -- with PYX shares trading up 28.1% at $21.58.

Today's upside comes in reaction to the leaf tobacco manufacturer's fiscal third-quarter results, which showed revenue surged 10% to $524 million. The company also gave an update on its cannabis operations, noting headway was made toward the launch of its cannabidiol e-liquid line, Korent.

Options traders are targeting even more upside for the shares. The February and March 20 calls are most active, and it looks like new positions are being purchased. If this is the case, call buyers' profit will accumulate the further north of $20 PYX stock climbs. Traders also appear to be buying to open the February and March 22.50 and 25 calls.

Today's call-skewed session just echoes the recent trend seen in Pyxus' options pits. At the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), speculative players have bought to open 5.48 calls for each put in the last two weeks.

With earnings in the rear-view mirror, short-term volatility expectations have plummeted -- pointing to relatively cheap options premiums at the moment, relatively speaking. Most recently, PYX's 30-day at-the-money implied volatility was docked at 110.7%, in the 16th percentile of its annual range.

Looking at the charts, Pyxus stock has kicked off 2019 with a bang, up 80% so far. However, the shares remain well off of their Oct. 9 eight-year high of $52.43, and are struggling to close a Nov. 8 earnings-induced bear gap.

pyx stock daily chart feb 12

SAGE Therapeutics Stock Hot Ahead of Earnings
The drug name is scheduled to report on Tuesday
Bear Signal Flashing for This Healthcare Stock Before Earnings
At least four analysts have issued price-target cuts on the stock this week
Signal Says This Retail Stock's on Sale
The shares pulled back this week on news of a Levi Strauss IPO
START YOUR DAY SMARTER.

Get Schaeffer's pre-market news bulletin every morning before the bell rings.
It's free to sign up.


Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


IRA/401K Investment Guide: 2019 Stock Market Crash
Use gold to protect any IRA, 401(k), or retirement account from a looming financial crisis.
3 of Today's Worst Nasdaq Stocks
The stocks are sitting out today's rally in the broader equities market
2019 Rally Continues for Stock Market
The Nasdaq is eyeing its longest weekly win streak since 2016
How American Lithium Tech May Be Poised for 614% Growth
A new lithium technology could change the face of lithium production forever.